177 related articles for article (PubMed ID: 36293074)
41. Peptidomimetic Src/pretubulin inhibitor KX-01 alone and in combination with paclitaxel suppresses growth, metastasis in human ER/PR/HER2-negative tumor xenografts.
Anbalagan M; Ali A; Jones RK; Marsden CG; Sheng M; Carrier L; Bu Y; Hangauer D; Rowan BG
Mol Cancer Ther; 2012 Sep; 11(9):1936-47. PubMed ID: 22784709
[TBL] [Abstract][Full Text] [Related]
42. Cysteinyl leukotriene receptor antagonists induce apoptosis and inhibit proliferation of human glioblastoma cells by downregulating B-cell lymphoma 2 and inducing cell cycle arrest.
Piromkraipak P; Parakaw T; Phuagkhaopong S; Srihirun S; Chongthammakun S; Chaithirayanon K; Vivithanaporn P
Can J Physiol Pharmacol; 2018 Aug; 96(8):798-806. PubMed ID: 29726704
[TBL] [Abstract][Full Text] [Related]
43. Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma.
Ravasi S; Capra V; Panigalli T; Rovati GE; Nicosia S
Biochem Pharmacol; 2002 Apr; 63(8):1537-46. PubMed ID: 11996896
[TBL] [Abstract][Full Text] [Related]
44. Time-dependent interactions of blood platelets and cancer cells, accompanied by extramedullary hematopoiesis, lead to increased platelet activation and reactivity in a mouse orthotopic model of breast cancer - implications for pulmonary and liver metastasis.
Kassassir H; Karolczak K; Siewiera KM; Wojkowska DW; Braun M; Watala CW
Aging (Albany NY); 2020 Mar; 12(6):5091-5120. PubMed ID: 32191918
[TBL] [Abstract][Full Text] [Related]
45. Role of Cysteinyl Leukotrienes in Allergic Rhinitis.
Shirasaki H; Himi T
Adv Otorhinolaryngol; 2016; 77():40-5. PubMed ID: 27115997
[TBL] [Abstract][Full Text] [Related]
46. Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes.
Shirasaki H; Seki N; Fujita M; Kikuchi M; Kanaizumi E; Watanabe K; Himi T
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):340-7. PubMed ID: 17941281
[TBL] [Abstract][Full Text] [Related]
47. Leukotriene D
Liu T; Barrett NA; Nagai J; Lai J; Feng C; Boyce JA
J Allergy Clin Immunol; 2021 Jul; 148(1):195-208.e5. PubMed ID: 33285161
[TBL] [Abstract][Full Text] [Related]
48. Leukotriene D
Al-Azzam N; Elsalem L
Life Sci; 2020 Nov; 260():118452. PubMed ID: 32956660
[TBL] [Abstract][Full Text] [Related]
49. Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models.
Walsh C; Tanjoni I; Uryu S; Tomar A; Nam JO; Luo H; Phillips A; Patel N; Kwok C; McMahon G; Stupack DG; Schlaepfer DD
Cancer Biol Ther; 2010 May; 9(10):778-90. PubMed ID: 20234193
[TBL] [Abstract][Full Text] [Related]
50. Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic.
Gelzinis JA; Szahaj MK; Bekendam RH; Wurl SE; Pantos MM; Verbetsky CA; Dufresne A; Shea M; Howard KC; Tsodikov OV; Garneau-Tsodikova S; Zwicker JI; Kennedy DR
FASEB J; 2023 May; 37(5):e22914. PubMed ID: 37043381
[TBL] [Abstract][Full Text] [Related]
51. Platelet deficiency in Tpo
Thiele W; Rothley M; Dimmler A; Bugert P; Salomó Coll C; Sleeman JP
Clin Exp Metastasis; 2018 Oct; 35(7):679-689. PubMed ID: 30043083
[TBL] [Abstract][Full Text] [Related]
52. [Zafirlukast (Accolate): a review of its pharmacological and clinical profile].
Murata Y; Sugimoto O
Nihon Yakurigaku Zasshi; 2002 Apr; 119(4):247-58. PubMed ID: 11979731
[TBL] [Abstract][Full Text] [Related]
53. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
54. Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice.
Yu XB; Dong RR; Wang H; Lin JR; An YQ; Du Y; Tang SS; Hu M; Long Y; Sun HB; Kong LY; Hong H
Psychopharmacology (Berl); 2016 May; 233(9):1739-49. PubMed ID: 26546369
[TBL] [Abstract][Full Text] [Related]
55. P2Y6 receptors require an intact cysteinyl leukotriene synthetic and signaling system to induce survival and activation of mast cells.
Jiang Y; Borrelli L; Bacskai BJ; Kanaoka Y; Boyce JA
J Immunol; 2009 Jan; 182(2):1129-37. PubMed ID: 19124756
[TBL] [Abstract][Full Text] [Related]
56. Leukotrienes in respiratory disease.
McMillan RM
Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
[TBL] [Abstract][Full Text] [Related]
57. The selective cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast regulates extracellular matrix remodeling.
Peng J; Zhou H; Kuang G; Xie L; Tian T; Liu R
Biochem Biophys Res Commun; 2017 Mar; 484(3):474-479. PubMed ID: 28088523
[TBL] [Abstract][Full Text] [Related]
58. Simultaneous blockade of platelet-derived growth factor-receptor and epidermal growth factor-receptor signaling and systemic administration of paclitaxel as therapy for human prostate cancer metastasis in bone of nude mice.
Kim SJ; Uehara H; Yazici S; Langley RR; He J; Tsan R; Fan D; Killion JJ; Fidler IJ
Cancer Res; 2004 Jun; 64(12):4201-8. PubMed ID: 15205332
[TBL] [Abstract][Full Text] [Related]
59. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
[TBL] [Abstract][Full Text] [Related]
60. Management of asthma with zafirlukast. Clinical experience and tolerability profile.
Spector SL
Drugs; 1996; 52 Suppl 6():36-46. PubMed ID: 8941502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
